Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?

被引：13
|
作者：
Siddiqi, Tanya [1 ]
Blaise, Didier [2 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
[2] Inst J Paoli I Calmettes, Dept Hematol, Programme Transplantat & Therapie Cellulaire, Marseilles, France
来源：
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; UNRELATED-DONORS; PROPHYLAXIS; MALIGNANCIES; TRIAL;
D O I：
10.1182/asheducation-2012.1.246
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
A 63-year-old male patient without siblings is treated for acute myeloid leukemia with poor prognostic cytogenetics. Despite achieving a first complete remission, he relapsed within the first year of diagnosis. He then achieved a second complete remission. A search for an HLA-identical unrelated donor identified a 10/10 possible match. The patient has several comorbidities (hematopoietic stem cell comorbidity index = 3) and it is recommended that he undergo a reduced-intensity conditioning regimen for allogeneic peripheral blood stem cell transplantation. The patient is well-read on allogeneic stem cell transplantation and asks you the merits of antithymocyte globulin that you propose to include in the conditioning regimen.
引用
收藏
页码：246 / 250
页数：5
相关论文
共 50 条
  • [41] Recombinant erythropoietin after reduced-intensity conditioning for allogeneic stem cell transplantation
    Blaise, D
    Ivanov, V
    Bilger, K
    Faucher, C
    Mohty, M
    Ladaique, P
    Sainty, D
    Chabannon, C
    Vey, N
    Maraninchi, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S327 - S328
  • [42] A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
    Le Blanc, K
    Remberger, M
    Uzunel, M
    Mansson, J
    Barkholt, L
    Ringdén, O
    TRANSPLANTATION, 2004, 78 (07) : 1014 - 1020
  • [43] Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial
    Gahrton, G.
    Bjoerkstrand, B.
    Iacobelli, S.
    Hegenbart, U.
    Gruber, A.
    Greinix, H.
    Volin, L.
    Narni, F.
    Musto, P.
    Beksac, M.
    Bosi, A.
    Milone, G.
    Corradini, P.
    Goldschmidt, H.
    de Witte, T.
    Morris, C.
    Niederwieser, D.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S9 - S10
  • [44] Allogeneic stem cell transplantation with reduced-intensity conditioning in patients with relapsed lymphoma
    Rivas, M.
    Berro, M.
    Belaustegui, S.
    Prates, V.
    Yantorno, S.
    Milone, J.
    Remaggi, G.
    Rolon, J. Martinez
    Milone, G.
    Basquiera, A.
    Garcia, J.
    Sturich, G.
    Kusminsky, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S257 - S258
  • [45] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [46] Neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation
    Barba, P.
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Sureda, A.
    Delgado, J.
    Briones, J.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S72 - S73
  • [47] The "cytokine storm" at the era of reduced-intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    Gaugler, B
    Faucher, C
    Vey, N
    Stoppa, AM
    Coso, D
    Viens, P
    Gastaut, JA
    Olive, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S79 - S80
  • [48] Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
    Zimmermann, SY
    Klingebiel, T
    Koehl, U
    Soerensen, J
    Schwabe, D
    BONE MARROW TRANSPLANTATION, 2002, 29 (12) : 957 - 962
  • [49] Comparison of Two Doses of Antithymocyte Globulin (ATG) in Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT)
    Issa, Hassan
    Ruppert, Amy S.
    Elder, Patrick
    Hofmeister, Craig
    Benson, Don M.
    Penza, Sam
    Andritsos, Leslie A.
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Blum, William
    Jaglowski, Samantha M.
    Devine, Steven M.
    Efebera, Yvonne A.
    BLOOD, 2015, 126 (23)
  • [50] Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation
    SY Zimmermann
    T Klingebiel
    U Koehl
    J Soerensen
    D Schwabe
    Bone Marrow Transplantation, 2002, 29 : 957 - 962
12345